Literature DB >> 2306139

Routine use of the left internal mammary artery graft in the elderly.

T J Gardner1, P S Greene, M F Rykiel, W A Baumgartner, D E Cameron, A S Casale, V L Gott, L Watkins, B A Reitz.   

Abstract

Left internal mammary artery (LIMA) grafts have better long-term patency rates than do saphenous vein grafts and result in improved late survival. The present study was undertaken to assess the results of LIMA grafting in the elderly. From 1980 through 1988, 723 patients 70 years of age or older had isolated coronary artery bypass grafting performed. During the first 5 years, only 11% of the elderly patients received LIMA grafts, whereas 86% having coronary artery bypass grafting since 1985 had LIMA grafts. Since 1986, LIMA use in the elderly has become routine, with 92% of patients receiving internal mammary artery grafts. During the first 5 years, elderly patients had a hospital mortality rate of 9.3%. Since 1985, the hospital mortality rate fell to 5.5%. In addition, the occurrence of major surgical complications was either unchanged or reduced in patients receiving LIMA grafts. Furthermore, late follow-up indicates a significantly improved 4-year survival rate in patients with internal mammary artery grafts compared with those without: 86 +/- 0.02% versus 77 +/- 0.03% (p less than 0.01). Analysis of multiple potential risk factors for early mortality was performed using multiple logistic regression and late survival using the Cox proportional hazards model. Although unmeasured predictor variables may confound retrospective analyses, LIMA grafting appears to be an independent predictor both of improved early and late survival.

Entities:  

Mesh:

Year:  1990        PMID: 2306139     DOI: 10.1016/0003-4975(90)90137-u

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  10 in total

1.  The effect of not using an internal mammary artery as a conduit for coronary artery bypass grafting.

Authors:  B J Leavitt
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

2.  Long term outcomes of radial artery grafting in patients undergoing coronary artery bypass surgery.

Authors:  James Tatoulis; Thomas A Schwann
Journal:  Ann Cardiothorac Surg       Date:  2018-09

Review 3.  Current status of coronary artery bypass grafting.

Authors:  Junjiro Kobayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-06-18

4.  Blood flow in the internal mammary artery after the administration of papaverine during coronary artery bypass grafting.

Authors:  H Hausmann; J Photiadis; R Hetzer
Journal:  Tex Heart Inst J       Date:  1996

5.  Perioperative features of coronary artery bypass grafting in patients aged 75 years or older.

Authors:  Toshiro Kobayashi; Kimikazu Hamano; Akihito Mikamo; Haruhiko Okada; Hidenori Gohra; Masaki Miyamoto; Tatsuro Oda; Kensuke Esato
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-04

6.  Good outcomes from cardiac surgery in the over 70s.

Authors:  A M Zaidi; A P Fitzpatrick; D J Keenan; N J Odom; G J Grotte
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

Review 7.  [Arterial myocardial revascularization in the 9th decade of life. Personal results and review of the literature].

Authors:  A Mortasawi; I C Ennker; A Albert; U Rosendahl; F Dalladaku; T Alexander; J Ennker
Journal:  Herz       Date:  1999-04       Impact factor: 1.443

8.  Cardiac surgery in patients age 80 years or older.

Authors:  W H Merrill; J R Stewart; W H Frist; J W Hammon; H W Bender
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

Review 9.  Coronary artery bypass surgery in elderly people.

Authors:  Arun Natarajan; Samad Samadian; Stephen Clark
Journal:  Postgrad Med J       Date:  2007-03       Impact factor: 2.401

10.  Risk factors for in-hospital mortality after coronary artery bypass grafting in patients 80 years old or older: a retrospective case-series study.

Authors:  Jacek Piątek; Anna Kędziora; Janusz Konstanty-Kalandyk; Grzegorz Kiełbasa; Marta Olszewska; Bryan HyoChan Song; Karol Wierzbicki; Irena Milaniak; Tomasz Darocha; Dorota Sobczyk; Bogusław Kapelak
Journal:  PeerJ       Date:  2016-12-01       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.